ArticleEuropean journal of case reports in internal medicine2025
Improvement of Microangiopathy in A Systemic Sclerosis Patient Following Hysterectomy for Leiomyoma: A Potential Role of Neoplasia.
Article in European journal of case reports in internal medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Systemic sclerosis (SSc) is a complex autoimmune disease characterised by vascular alterations, immune dysregulation and fibrosis. Microangiopathy is a hallmark of SSc and can be assessed non-invasively using nailfold videocapillaroscopy (NVC). Case description: This is a case of a 50-year-old Caucasian woman with anticentromere-positive SSc, experiencing Raynaud's phenomenon and hand oedema. She met the 2013 ACR/EULAR classification criteria for SSc. Despite stable nifedipine therapy, her vasospastic episodes were only partially controlled. In March 2024, she underwent a total hysterectomy for a symptomatic uterine leiomyoma. Postoperatively, there was a marked improvement in Raynaud's phenomenon and NVC findings. Discussion: This case suggests a potential link between neoplastic processes and exacerbation of SSc-related microangiopathy. It is hypothesised that tumour-derived factors, such as inflammatory cytokines and angiogenic mediators, may contribute to endothelial dysfunction and worsen vascular impairment. The observed microvascular improvement following tumour removal supports the hypothesis that neoplasms may act as disease-modifying factors in SSc. Further studies are needed to determine whether systematic malignancy screening in selected SSc patients may help identify modifiable triggers of microangiopathy. LEARNING POINTS: Observation of clinical and microvascular improvement in a systemic sclerosis patient is recommended following the removal of a uterine leiomyoma.The potential aggravating role of neoplastic processes in systemic sclerosis-associated microangiopathy.The importance of timely identification and management of neoplasms in systemic sclerosis patients to modulate disease progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.